New derivatives of imidazole as potential anticancer agents.
A series of monocyclic amidinohydrazones 2a-h was prepared from the reaction of N-(4,5-dihydro-1H-imidazol-2-yl)-N-(2-hydroxy-ethyl) hydrazine hydroiodide 1 with various aromatic aldehydes. Some of them were subjected to an esterification with acetic anhydride to give 2a-d. Compounds 2a,c,d,e,f,h and 3c were tested for their anticancer and anti-HIV activity.
Krezel
I
I
Department of Pharmaceutical Chemistry and Drug Analysis, Medical University of Lódz, Poland.
D019380:Anti-HIV Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000138:chemical synthesis* / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D007093:Imidazoles